Hsbc Holdings PLC Mustang Bio, Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.32 - $8.27 $604 - $15,622	-1,889 Reduced 1.7%	109,052 $42,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $4,411 - $69,048	-9,590 Reduced 7.96%	110,941 $54,000
Q4 2021 Feb 11, 2022	BUY	$1.66 - $2.64 $100,106 - $159,205	60,305 Added 100.13%	120,531 $200,000
Q3 2021 Nov 12, 2021	BUY	$2.58 - $3.36 $125,764 - $163,786	48,746 Added 424.62%	60,226 $156,000
Q2 2021 Aug 13, 2021	BUY	$2.7 - $3.81 $30,996 - $43,738	11,480 New	11,480 $38,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.